Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Gauthier

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|August 28, 2019
As-needed β agonist-inhaled corticosteroid in mild asthmaMarc Gauthier, Sally E Wenzel
American Journal of Respiratory and Critical Care Medicine|July 11, 2015
Evolving Concepts of AsthmaMarc Gauthier, Anuradha Ray, Sally E Wenzel
Immunological Reviews|February 24, 2025
T1-T2 Interplay in the Complex Immune Landscape of Severe AsthmaMarc Gauthier, Sagar L Kale, Anuradha Ray
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Toxaphene, but not beryllium, induces human neutrophil chemotaxis and apoptosis via reactive oxygen species (ROS): involvement of caspases and ROS in the degradation of cytoskeletal proteinsValérie Lavastre, Charles J Roberge, Martin Pelletier, et al.
Physiological Reviews|January 10, 2020
Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?Anuradha Ray, Matthew Camiolo, Anne Fitzpatrick, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotypeMatthew Camiolo, Marc Gauthier, Naftali Kaminski, et al.
Current Opinion in Immunology|March 27, 2021
Immune responses and exacerbations in severe asthmaMatthew J Camiolo, Sagar L Kale, Timothy B Oriss, et al.
Brain and Behavior|February 28, 2018
Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysisGwendal Le Masson, Guilhem Solé, Claude Desnuelle, et al.
The Journal of Allergy and Clinical Immunology|June 19, 2021
Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammationMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.
JCI Insight|July 7, 2017
Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 biasMarc Gauthier, Krishnendu Chakraborty, Timothy B Oriss, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|August 28, 2019
As-needed β agonist-inhaled corticosteroid in mild asthmaMarc Gauthier, Sally E Wenzel
American Journal of Respiratory and Critical Care Medicine|July 11, 2015
Evolving Concepts of AsthmaMarc Gauthier, Anuradha Ray, Sally E Wenzel
Immunological Reviews|February 24, 2025
T1-T2 Interplay in the Complex Immune Landscape of Severe AsthmaMarc Gauthier, Sagar L Kale, Anuradha Ray
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Toxaphene, but not beryllium, induces human neutrophil chemotaxis and apoptosis via reactive oxygen species (ROS): involvement of caspases and ROS in the degradation of cytoskeletal proteinsValérie Lavastre, Charles J Roberge, Martin Pelletier, et al.
Physiological Reviews|January 10, 2020
Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?Anuradha Ray, Matthew Camiolo, Anne Fitzpatrick, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotypeMatthew Camiolo, Marc Gauthier, Naftali Kaminski, et al.
Current Opinion in Immunology|March 27, 2021
Immune responses and exacerbations in severe asthmaMatthew J Camiolo, Sagar L Kale, Timothy B Oriss, et al.
Brain and Behavior|February 28, 2018
Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysisGwendal Le Masson, Guilhem Solé, Claude Desnuelle, et al.
The Journal of Allergy and Clinical Immunology|June 19, 2021
Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammationMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.
JCI Insight|July 7, 2017
Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 biasMarc Gauthier, Krishnendu Chakraborty, Timothy B Oriss, et al.
Pageof 2